Add To My Watchlist

Overall Rating: 45 Neutral

Action to take: WATCH
Neutral stocks are expected to perform in line with the market over the next 12 months.
45
Priced Based
Momentum
77
Size
66
Volatility
26
Fundamental Based
Value
35
Quality
12
Growth
77
Negative Factors (Bottom 20%)
Quality: Stocks of the lowest quality are exposed to high operational and financial risk.
Collapse Detail

Latest Insights on QURE

senior citizen speaks with doctor Gene Therapy Power Stock Develops Treatments for Alzheimer’s and More The number of American 65 and up with Alzheimer's will double by 2060. This biopharma Power Stock develops gene therapies for Alzheimer's and other diseases. It rates an 87 on our system.